ASO-mediated Dnm2 knockdown prevents and reverts myotubular myopathy in mice

被引：0
|
作者：
Tasfaout, H. [1 ]
Buono, S. [1 ]
Guo, S. [2 ]
Kretz, C. [1 ]
Monia, B. [2 ]
Cowling, B. [1 ]
Laporte, J. [1 ]
机构：
[1] IGBMC, Illkirch Graffenstaden, France
[2] Ionis Pharmaceut, Carlsbad, CA USA
来源：
NEUROMUSCULAR DISORDERS | 2016年 / 26卷
关键词：
D O I：
10.1016/j.nmd.2016.06.448
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
T.O.14
引用
收藏
页码：S209 / S210
页数：2
相关论文
共 50 条
  • [31] Centronuclear myopathy with cataracts due to a novel heterozygous mutation in the dynamin 2 (DNM2) gene
    Jungbluth, H.
    Cullup, T.
    Lillis, S.
    Zhou, H.
    Sewry, C.
    Abbs, S.
    Muntoni, F.
    NEUROMUSCULAR DISORDERS, 2009, 19 (8-9) : 636 - 636
  • [32] A case of de novo dynamin 2 (DNM2)-related centronuclear myopathy with electrical but not clinical myotonia
    Huang, Xiao
    Liu, Xiang-Yi
    Chen, Lu
    Sun, A-Ping
    Zhang, Ying-Shuang
    Zheng, Dan-Feng
    Zhong, Yan-Feng
    Fan, Dong-Sheng
    CHINESE MEDICAL JOURNAL, 2020, 133 (24) : 3023 - 3024
  • [33] Tamoxifen increases survival, improves motor function and reduces levels of BIN1 and DNM2 in a mouse model of X-linked centronuclear (myotubular) myopathy
    Gayi, E.
    Ismail, H.
    Cowling, B.
    Neff, L.
    Laporte, J.
    Scapozza, L.
    Dorchies, O.
    NEUROMUSCULAR DISORDERS, 2017, 27 : S246 - S247
  • [34] A case of de novo dynamin 2 (DNM2)-related centronuclear myopathy with electrical but not clinical myotonia
    Huang Xiao
    Liu Xiang-Yi
    Chen Lu
    Sun A-Ping
    Zhang Ying-Shuang
    Zheng Dan-Feng
    Zhong Yan-Feng
    Fan Dong-Sheng
    中华医学杂志英文版, 2020, 133 (24) : 3023 - 3024
  • [35] Sporadic centronuclear myopathy with muscle pseudohypertrophy, neutropenia, and necklace fibres due to a DNM2 mutation
    Romero, Norma Beatriz
    Bevilacqua, Jorge A.
    Oldfors, Anders
    Fardeau, Michel
    NEUROMUSCULAR DISORDERS, 2011, 21 (02) : 148 - 148
  • [36] A DNM2 Centronuclear Myopathy Mutation Reveals a Link between Recycling Endosome Scission and Autophagy
    Puri, Claudia
    Manni, Marco M.
    Vicinanza, Mariella
    Hilcenko, Christine
    Zhu, Ye
    Runwal, Gautam
    Stamatakou, Eleanna
    Menzies, Fiona M.
    Mamchaoui, Kamel
    Bitoun, Marc
    Rubinsztein, David C.
    DEVELOPMENTAL CELL, 2020, 53 (02) : 154 - +
  • [37] New histopathlogical features in Centronuclear Myopathy caused by DNM2 mutations - clues to disease pathogenesis
    Oates, E. C.
    Ilkovski, B.
    North, K. N.
    Clarke, N. F.
    NEUROMUSCULAR DISORDERS, 2011, 21 (9-10) : 693 - 693
  • [38] Imaging-based evaluation of pathogenicity by novel DNM2 variants associated with centronuclear myopathy
    Fujise, Kenshiro
    Okubo, Mariko
    Abe, Tadashi
    Yamada, Hiroshi
    Takei, Kohji
    Nishino, Ichizo
    Takeda, Tetsuya
    Noguchi, Satoru
    HUMAN MUTATION, 2022, 43 (02) : 169 - 179
  • [39] Sporadic centronuclear myopathy with muscle pseudohypertrophy, neutropenia, and necklace fibers due to a DNM2 mutation
    Liewluck, Teerin
    Lovell, Tracy L.
    Bite, Anna V.
    Engel, Andrew G.
    NEUROMUSCULAR DISORDERS, 2010, 20 (12) : 801 - 804
  • [40] DNM2 levels normalization improves muscle phenotypes of a novel mouse model for moderate centronuclear myopathy
    Neves, Juliana de Carvalho
    Moschovaki-Filippidou, Foteini
    Bohm, Johann
    Laporte, Jocelyn
    MOLECULAR THERAPY NUCLEIC ACIDS, 2023, 33 : 321 - 334
12345